1. GSK aims to make 1B doses of vaccine booster for multiple COVID-19 partners — Protalix and Chiesi get close to potential Fabry disease treatment approval — AstraZeneca locks up COVID-19 vaccine supply with Oxford BioMedica deal — See more on our front page news Stay updated with the latest pharma-related coronavirus news on our new page
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

Dan Sadbury is a sellout

Discussion in 'Amylin' started by Anonymous, Jun 30, 2012 at 8:08 PM.

Tags: Add Tags
  1. Anonymous

    Anonymous Guest

    Can I hear an Amen? AMEN!
     

  2. Anonymous

    Anonymous Guest

    AMEN! Too bad it cost so much to get rid of him and the other worthless execs.
     
  3. Anonymous

    Anonymous Guest

    Amen.
    I hope EC and DB not involved with BMS recent insider trading mess with amylin buyouts....
    Ahahaha....your 60 million...
     
  4. Anonymous

    Anonymous Guest

    Dan has never been an advocate of company growth. What he wanted is to sell, sell, sell and make as much money so that he don't have to work in his life again. He very well planned to get rid of pro-growth leaders such as Ginger, Ted and Joe Cook. Mission accomplished and bad people always win. It's a sad story and can be written as NY best seller. Anyone can name a good title??
     
  5. Anonymous

    Anonymous Guest

    He is gone - with gold lining his pockets.
     
  6. #26 Anonymous, Aug 10, 2012 at 6:33 PM
    Last edited by a moderator: Aug 1, 2016 at 9:08 AM
    Anonymous

    Anonymous Guest

    Hope he will never venture into any other industry. May his mind rest in peace.